ABSTRACT Background: Diabetes mellitus is a progressive chronic disease with a rapidly increasing prevalence and is associated with significantly high frequency of long-term complications. Despite the scientific evidence and the high degree of consensus reached by experts, clinicians, and planners, achieving control targets remains a challenge. Aim/Objective: To assess the sex and age differences in the achievement of control targets in patients with type 2 diabetes. Methods: This was a cross sectional study among type2 diabetes patient at King Khalid University Hospital, Riyadh, Saudi Arabia. Eligible subjects were identified from the KSU-MC database and data were abstracted in a specially designed case report form. Results: There were 418 (66.9%) patients who had uncontrolled DM. There was a significant association between glycaemic control and diabetic nephropathy, neuropathy , and diabetic retinopathy.Triglyceride and FBG levels were significantly higher in the uncontrolled DM group while HDL level was significantly lower. Females showed a significantly higher prevalence of orthostatic hypotension, gastroparesis, diabetic neuropathy, and diabetic retinopathy. Additionally, they had significantly higher levels of LDL, HDL and cholesterol compared to males. The prevalence of gastroparesis and diabetic neuropathy were significantly higher among patients who are > 57 years old. Moreover, HDL level was significantly higher among the > 57 years old group, while the levels of LDL, cholesterol, triglycerides and FBG were significantly higher in the ≤ 57 years old group. Conclusion: There is a significant association between glycemic control and diabetes related complications. In addition, female gender tends to have diabetes complications and dyslipidemia compared to male gender. Moreover, dyslipidemia and abnormal fasting blood glucose were common among middle age patient.
INTRODUCTION
Diabetes mellitus is a progressive chronic disease with a rapidly increasing prevalence in both developing and developed countries 1 . It is associated with significantly high frequency of long term complications which reduce life quality and expectancy. The well-known Diabetes Control and Complication Trial (DCCT) and the United Kingdom Prospective Diabetes Study (UKPDS) showed that improved glycemic control was associated with a reduction in the risk of complications in type 1 and type 2 diabetics, respectively 2, 3 . In developed countries, many studies have shown that, controlling risk factors has effectively reduced the CVD mortality by 40 to 60% 4 . However, despite the scientific evidence and the high degree of consensus reached by experts, clinicians, and planners, achieving control targets remains a challenge. Several studies have shown that there is an important gap between recommendations and clinical practice, and only a minority of diabetic patients achieves the optimal control of glycaemia and cardiovascular risk factors
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. Saudi Arabia is country facing an epidemic of diabetes mellitus, where 50% of its population are either diabetic or pre-diabetic 9 and ranked the 7th among the top ten countries of high diabetes prevalence. There was a study done at king Khalid university hospital ,Riyadh, Saudi Arabia aimed to assess gender differences in frequency distribution of lipid and glycaemic control . It showed that Saudi diabetic women had poor glycemic and lipid control as compared to male diabetics. Moreover, they tend to be more obese. Further studies are needed to explore the exact causes of these complications . Expert Panels have to be organized on the Detection, Evaluation, and Treatment of differences which could be attributed to hormonal, lifestyle changes and/or other causes.
Hence identifying the sex and age differences in the achievement of control targets in patients with type 2 diabetes will introduce an insight for healthcare leaders to set screening and 2267 early prevention programs, and implement new clinical practice guidelines for the clinical care and management of type 2 diabetes, and for reducing the prevalence of such devastating complications. We conducted this study to determine the degree to which control targets of glycaemia were achieved among patients with type 2 diabetes and to investigate differences related to sex and age and in this population as well as determining the degree to which control targets of lipid derangement were achieved among patients with type 2 diabetes.
METHODS
This was a retrospective cross-sectional study conducted among Type 2 diabetic patients registered at KSU-MC electronic system. Patients were identified and abstractors reviewed the patient's electronic files to collect the data on to a case report form. Inclusion criteria were type 2 diabetes, age ≥18 years old, and Saudi, while the exclusion criteria were Type 1 DM, Gestational Diabetes mellitus (GDM), Secondary diabetes and impaired glucose tolerance (IGT), < 18years of age, with history of nephrotic syndrome, acute or chronic renal failure, acute infection, stroke, acute diabetic stat, on oral contraceptive pills, steroids and with thyroid diseases.
Data collected included the demographic profile of the patient (age, gender, marital status, educational status, monthly income, anthropometric measurements including BMI. Clinical and laboratory data collected included latest results available in the last 15 months prior to extraction date. Other pertinent data collected included diabetes duration, family history of diabetes, glycemic profile includeing HbA1C, FBG,RBS,2HPP, treatment, diet, insulin (type and dose), oral hypoglycemic agents (type and dose), hypertension, and hyperlipidemia, All data were encoded in a specially designed SPSS sheet. Data was analyzed by using Statistical Package for Social Studies (SPSS 22; IBM Corp., New York, NY, USA). Continuous variables were expressed as mean ± standard deviation and categorical variables were expressed as percentages. The t-test was used for continuous variables and chi square test was used for categorical variables. A binary logistic regression model was used to assess the differences in the degree of achievement of control targets between the two genders where age and the duration of diabetes were included as covariates. A p-value <0.05 was considered statistically significant.
Study data was coded without the use of names, medical record numbers, National ID numbers, initials, or other identifiable personal information. A unique code number was generated for each study subject and data was stored at a secure location available only to the study investigators.
RESULTS
There were a total of 625 patients included in the study, 284 (45.4%) males and 341 (54.6%) females. Mean age of all patients was 58.11 ± 11.15 years (range of 21 to 103 years old). Mean duration of DM was 9.11 ± 6.91 years (range: 4 months -40 years). There were 549 (87.8%) who were married. There were 485 (77.6%) patients who had a family history of DM. Thirty four (5.4%) were smokers. Table 1 shows the detailed clinical and laboratory findings of all 625 patients. Table 2 shows the significant differences in age, gender distribution, prevalence of complications, and clinic-laboratory findings between controlled and uncontrolled DM based on HgbA1C levels. There were 418 (66.9%) who had uncontrolled DM.
There were significantly more patients who had diabetic nephropathy, diabetic neuropathy, and diabetic retinopathy in the uncontrolled DM group compared to those whose DM is controlled (p values of 0.023, 0.013, and <0.001, respectively). Duration of diabetes was significantly longer in the uncontrolled DM group (10.34 ± 7.11 years versus 6.62 ± 5.75 years, p=0.001). Triglyceride and FBG levels were significantly higher in the uncontrolled DM group (p values of <0.001 and <0.001, respectively), and the HDL level was significantly lower in the uncontrolled DM group (p<0.001). However, the prevalence of sexual dysfunction was significantly higher among the controlled DM group (p=0.036). There were no significant differences in the age and gender, BMI, in the prevalence of orthostatic hypotension, gastroparesis, vasculopathy, and in the levels of LDL and cholesterol between uncontrolled and controlled DM patients. Table 3 shows the comparison of the prevalence of complications, clinical and laboratory values according to gender. Females showed significantly higher prevalence of orthostatic hypotension, gastroparesis, diabetic neuropathy, and diabetic retinopathy compared to males (p values of 0.008, 0.046, <0.001, and 0.007, respectively). Also, females had a significantly higher levels of LDL, HDL and cholesterol compared to males (p values of 0.004, <0.001, and <0.001, respectively). Age and BMI were significantly higher among females (p values of 0.001 and <0.001 respectively). There were no significant differences in the prevalence of sexual dysfunction, diabetic vasculopathy, diabetic nephropathy, duration of diabetes, and serum triglycerides, FBG and HbA 1 C levels between males and females. Table 4 shows the comparison of the prevalence of complications, clinical and laboratory values according to age groups (between ≤ 57 years old and those more than 57 years old). The prevalence of gastroparesis and diabetic neuropathy were significantly more among patients who are > 57 years old compared to those ≤ 57 years old (p=0.011 and 0.013, respectively). The duration of diabetes and HDL level were also significantly higher among the > 57 years old group (p<0.001 and 0.007, respectively), however, the levels of LDL, cholesterol, triglycerides and FBG were significantly higher in the ≤ 57 years old group than the > 57 years old group (p=0.004, 0.011, 0.013, and 0.021, respectively). There were no significant differences in the prevalence of gastroparesis, sexual dysfunction, diabetic vasculopathy, nephropathy, retinopathy, and in BMI and HbA 1 C level. 
DISCUSSION
The findings of our study demonstrate a significant increase in macrovascular and microvascular complications in uncontrolled DM patient compared to controlled patient. A prospective study found that the incidence of chronic complications significantly associated to the degree of hyperglycaemia 10 . In regards to studying the association between diabetes complications and gender, many studies found that females tend to have higher prevalence of complications than males 11, 12 . Moreover, some studies have found a positive association between females and diabetic retinopathy 13, 14 while other have found higher risk among males 15, 16 . However, males showed signs of diabetic neuropathy earlier 17 , and more frequent than females 18 . In addition, diabetic nephropathy was more common in males than females
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, which is against our finding. Furthermore, Females reported to have higher prevalence and severity of symptoms of gastroparesis comparing to males, especially obese females with long duration of Diabetes and high HbA1c 20 . This finding is in line with our conclusion. In a large epidemiological study conducted in US about diabetic retinopathy prevalence among adults, the authors found that the prevalence of diabetic retinopathy among persons with DM did not vary substantially by age group or and only small differences were observed, and their pattern was inconsistent. Additionally, they found that the strongest association of DR with age was observed among Hispanic persons with DM 21 . This is in an accordance with the current study finding, in which elder diabetic people aged >57 showed a nonsignificant higher prevalence of diabetic retinopathy.
About half of older diabetic patients with long diabetes duration (>25 years) have comorbid diabetic peripheral neuropathy (DPN) which is a high risk factor for falling 22 , especially among patients who are female, have diabetic retinopathy, stroke, hypertension, dyslipidemia, and a history of foot ulcers
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. DPN can be associated with functional impairment that worsens by increasing DPN severity, and quality of life can also be affected 22 . Univariate analysis of data in a Malaysian study aimed to assess the prevalence of peripheral neuropathy and its associated factors among elderly type 2 diabetes patients showed that age was significantly associated with peripheral neuropathy 24 . This finding is in line with that of the present study. Despite being statistically nonsignificant, the present results showed higher prevalence of diabetic vasculopathy and nephropthy among elderly group, and this is similar to what has been previously reported in the literature 25 . It has been reported in a review article published in 2013 that plasma cholesterol concentration increases with age from puberty until 45 to 55 years old in males, then decreases. For females, it continues to increase until about 10 years later, after which it declines in the last decades of life 26 . In line with this, our study showed a significant lower plasma cholesterol level in people aged >57 compared to those ≤57. The decrease in cholesterol level by increasing age can be explained by a reduction in LDL synthesis as a result of decreased liver function, but may also be due to a survival bias in subjects with lower levels. Additionally, previous studies have suggested that elderly individuals have relatively satisfactory levels of blood lipid management 27, 28 . Although conflicting findings have revealed in a previous study, that lipid management levels did not differ significantly between elderly (≥65years) and middle aged (<65 years) groups 29 . The discrepancy between the findings of the present and the previous study 29 could be related to the differences in the definitions of dyslipidemia, and the statistical models and their adjustment for confounders.
In Sukyung et al. study about management levels of metabolic risk factors in patients with type 2 diabetes mellitus, that used data from the Korean National Health and Nutrition Examination Survey (1998-2014), it was found an agreement with ours in regards to FBG, and showed that the elderly patients group (≥65years) had a significant lower prevalence of hyperglycemia than the middle-aged group (<65 years) during most survey years 29 . Similarly, previous studies have reported that older adults have better management of blood glucose than middle-aged adults 28, 30-32 , which is consistent with the findings of the current study. This can be explained by the reason that older patients tend to have better medication adherence 33 . In contrast to what Sukyung Cho et al. reported in their study 29 , the current study showed no difference in diabetic dietary therapy between elderly group and the middle aged one.Orthostatic hypotension (OH) was more common in elderly patients with DM, and its prevalence was reported to be 24.7% among DM aged ≥60 years old 34 . In contrast to a previous study which showed that age is not associated with orthostatic hypotension
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, the current study showed that OH prevalence significantly increased among elderly. On the other hand, and in accordance with our results, several studies reported that age is a significant risk factor for OH in diabetic patients [35] [36] [37] .
